医疗设备公司Glaukos Corp（GKOS）在发布第一季度财报后，股价在盘后交易中大跌6.63%。尽管公司的业绩超出了分析师的预期，但投资者似乎对公司的整体表现仍持谨慎态度。
根据公司发布的财报，Glaukos在截至3月31日的季度中，调整后每股亏损为0.22美元，优于分析师平均预期的0.35美元亏损。公司营收同比增长24.6%，达到1.0666亿美元，同样超过了分析师预期的1.025亿美元。然而，尽管业绩有所改善，公司在本季度仍录得1815万美元的亏损。
尽管季度业绩优于预期，但投资者似乎更关注公司的长期发展前景。值得注意的是，Glaukos的股价今年以来已下跌37.4%，这可能反映了市场对公司持续亏损的担忧。此外，虽然公司的亏损幅度收窄，但仍未能实现盈利，这可能是导致股价在财报发布后下跌的原因之一。投资者可能需要看到更明确的盈利改善信号，才能重建对公司前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.